CLINICAL_TRIALS
trial_result
· 2021-07-15
Clinical Trial Update: Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers [Phase 1]
Summary
Phase 1 trial updating the interaction between omeprazole and gliclazide in CYP2C19 normal/ultrarapid metabolizers; completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Sarajevo | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2021-07-15